Did you know that peripheral arterial disease (PAD) is asymptomatic in 50-75% of cases(1)? This is an alarming statistic, especially when we consider that PAD is a strong risk factor for cardiovascular disease (the leading cause of death worldwide).
Considering also that 25% of cases of sudden cardiac death have no prior symptoms or appreciable risk factors(2), the need for early detection of PAD becomes clear.
As well as its link to mortality, PAD is a leading cause of morbidity - PAD can lead to foot ulceration, which can lead to amputation - with devastating physical and emotional impacts on the individual as well as significant financial implications for the health system.
Currently, PAD is underdiagnosed, hence undertreated(3). There is a compelling need for more targeted screening in at-risk populations to reduce morbidity and mortality rates in people with PAD.
One of the reasons for underdiagnosis is inadequate screening due to a lack of knowledge among Health Professionals of which assessments are most effective in making a diagnosis of PAD. Commonly used tests for PAD have limited sensitivity in the most at-risk populations (4). Clinical assessments range from simple observation to more complex ABI (ankle-brachial index). Research supports the use of some, but not all of these assessment techniques. Below are some of the most common:
Another barrier to effective screening is that certain guidelines don’t reflect the latest evidence.
With all this in mind, I’m sure you’re keen to learn more. Join us on Monday, August 6th at 7.30PM (AEST) for a one-hour webinar, where our expert presenter Dr Sylvia McAra will share a best-practice approach to assessing PAD using evidence-based clinical tests.
This is a multidisciplinary webinar for Podiatrist, GPs and Nurses. Click here to read more and enrol.
References:
The Medcast medical education team is a group of highly experienced, practicing GPs, health professionals and medical writers.
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreGenetic testing in general practice: Dr. Alan Ma explains which tests GPs can order, when to refer, and how the PRECISE portal supports confident testing and referral decisions.
MyMedicare is now part of routine general practice, with practical implications for billing, continuity of care, and practice systems. This FastTrack clarifies important points regarding eligibility, impacts on the GPCCMP billing, and how to avoid rejected claims. 30mins each RP and EA available.
Genomics is now part of everyday general practice. The PRECISE Genomics in Primary Care hub gives Australian GPs fast, practical tools to recognise genetic red flags, guide testing and support timely referrals.